Trials / Completed

CompletedNCT00411567

A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

An Open Label Study to Assess the Utility of Measuring Markers of Inflammation, to Detect Transition From Optimal to Sub-Optimal Inhaled Corticosteroid Therapy in Moderate-Severe Bronchial Asthma

Status: Completed
Phase: Phase 1 / Phase 2
Study type: Interventional
Enrollment: 26 (planned)

Sponsor: Novartis · Industry
Sex: All
Age: 18 Years – 75 Years
Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate/assess the treatment of moderate to severe asthmatics with inhaled corticosteroid.

Conditions

Bronchial Asthma

Interventions

Type	Name	Description
DRUG	inhaled corticosteroid therapy

Timeline

Start date: 2006-07-01
First posted: 2006-12-14
Last updated: 2007-06-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00411567. Inclusion in this directory is not an endorsement.